The global market for Integrated Precision Diagnosis and Treatment Solution was valued at US$ 2310 million in the year 2024 and is projected to reach a revised size of US$ 5132 million by 2031, growing at a CAGR of 12.1% during the forecast period.

Integrated Precision Diagnosis and Treatment Solution Market

The integrated precision medicine solution is a comprehensive service system based on multidimensional data integration, artificial intelligence analysis, and personalized medicine strategies. It aims to provide systematic support throughout the entire process, from disease prevention, early screening, precision diagnosis, personalized treatment to efficacy evaluation and follow-up management. This solution typically integrates genomics, radiomics, clinical data, pathology information, and lifestyle data. Through intelligent algorithms and decision support tools, it provides doctors and patients with personalized treatment plans, optimizing treatment plans, maximizing resource utilization, and improving patient prognosis, while also enhancing the operational efficiency and management level of medical institutions.

The downstream users of the integrated precision medicine solution are primarily medical institutions, diagnostic laboratories, pharmaceutical companies, and research institutions, providing a complete service from gene testing, molecular diagnostics, pathological analysis to personalized treatment plans. Downstream clients utilize these solutions for precision medication guidance, early disease screening, and clinical trial design, significantly improving treatment outcomes and reducing unnecessary medical costs. In terms of gross profit margin, due to the involvement of high-end instruments and equipment, reagents and consumables, and professional services in precision medicine, the overall gross profit margin is typically around 56%.

North American market for Integrated Precision Diagnosis and Treatment Solution is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Integrated Precision Diagnosis and Treatment Solution is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Integrated Precision Diagnosis and Treatment Solution in Medical Institutions is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Integrated Precision Diagnosis and Treatment Solution include Illumina, QIAGEN, Caris Life Sciences, Foundation Medicine, Guardant Health, NeoGenomics, Myriad Genetics, Thermo Fisher Scientific, Roche Holding AG, Abbott Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Integrated Precision Diagnosis and Treatment Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Integrated Precision Diagnosis and Treatment Solution.

The Integrated Precision Diagnosis and Treatment Solution market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Integrated Precision Diagnosis and Treatment Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, by Scenario and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Integrated Precision Diagnosis and Treatment Solution companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Integrated Precision Diagnosis and Treatment Solution Market Report

Report Metric	Details
Report Name	Integrated Precision Diagnosis and Treatment Solution Market
Accounted market size in year	US$ 2310 million
Forecasted market size in 2031	US$ 5132 million
CAGR	12.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Genomics Proteomics Metabolomics Radiomics
Segment by Scenario	Clinical Diagnosis and Treatment Oriented Prevention and Health Management Drug Research and Development Support
Segment by Delivery Format	Software Platform Type Laboratory Service Type
Segment by Application	Medical Institutions Research and Academic Institutions
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Illumina, QIAGEN, Caris Life Sciences, Foundation Medicine, Guardant Health, NeoGenomics, Myriad Genetics, Thermo Fisher Scientific, Roche Holding AG, Abbott Laboratories, GE HealthCare, Tempus Labs, Personalis, Genome Medical, Endeavor Biomedicines
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Scenario etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Integrated Precision Diagnosis and Treatment Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Integrated Precision Diagnosis and Treatment Solution Market growing?

Ans: The Integrated Precision Diagnosis and Treatment Solution Market witnessing a CAGR of 12.1% during the forecast period 2025-2031.

What is the Integrated Precision Diagnosis and Treatment Solution Market size in 2031?

Ans: The Integrated Precision Diagnosis and Treatment Solution Market size in 2031 will be US$ 5132 million.

Who are the main players in the Integrated Precision Diagnosis and Treatment Solution Market report?

Ans: The main players in the Integrated Precision Diagnosis and Treatment Solution Market are Illumina, QIAGEN, Caris Life Sciences, Foundation Medicine, Guardant Health, NeoGenomics, Myriad Genetics, Thermo Fisher Scientific, Roche Holding AG, Abbott Laboratories, GE HealthCare, Tempus Labs, Personalis, Genome Medical, Endeavor Biomedicines

What are the Application segmentation covered in the Integrated Precision Diagnosis and Treatment Solution Market report?

Ans: The Applications covered in the Integrated Precision Diagnosis and Treatment Solution Market report are Medical Institutions, Research and Academic Institutions

What are the Type segmentation covered in the Integrated Precision Diagnosis and Treatment Solution Market report?

Ans: The Types covered in the Integrated Precision Diagnosis and Treatment Solution Market report are Genomics, Proteomics, Metabolomics, Radiomics

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Genomics

1.2.3 Proteomics

1.2.4 Metabolomics

1.2.5 Radiomics

1.3 Market by Scenario

1.3.1 Global Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate by Scenario: 2020 VS 2024 VS 2031

1.3.2 Clinical Diagnosis and Treatment Oriented

1.3.3 Prevention and Health Management

1.3.4 Drug Research and Development Support

1.4 Market by Delivery Format

1.4.1 Global Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate by Delivery Format: 2020 VS 2024 VS 2031

1.4.2 Software Platform Type

1.4.3 Laboratory Service Type

1.5 Market by Application

1.5.1 Global Integrated Precision Diagnosis and Treatment Solution Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 Medical Institutions

1.5.3 Research and Academic Institutions

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Integrated Precision Diagnosis and Treatment Solution Market Perspective (2020-2031)

2.2 Global Integrated Precision Diagnosis and Treatment Solution Growth Trends by Region

2.2.1 Global Integrated Precision Diagnosis and Treatment Solution Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Integrated Precision Diagnosis and Treatment Solution Historic Market Size by Region (2020-2025)

2.2.3 Integrated Precision Diagnosis and Treatment Solution Forecasted Market Size by Region (2026-2031)

2.3 Integrated Precision Diagnosis and Treatment Solution Market Dynamics

2.3.1 Integrated Precision Diagnosis and Treatment Solution Industry Trends

2.3.2 Integrated Precision Diagnosis and Treatment Solution Market Drivers

2.3.3 Integrated Precision Diagnosis and Treatment Solution Market Challenges

2.3.4 Integrated Precision Diagnosis and Treatment Solution Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Integrated Precision Diagnosis and Treatment Solution Players by Revenue

3.1.1 Global Top Integrated Precision Diagnosis and Treatment Solution Players by Revenue (2020-2025)

3.1.2 Global Integrated Precision Diagnosis and Treatment Solution Revenue Market Share by Players (2020-2025)

3.2 Global Top Integrated Precision Diagnosis and Treatment Solution Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Integrated Precision Diagnosis and Treatment Solution Revenue

3.4 Global Integrated Precision Diagnosis and Treatment Solution Market Concentration Ratio

3.4.1 Global Integrated Precision Diagnosis and Treatment Solution Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Integrated Precision Diagnosis and Treatment Solution Revenue in 2024

3.5 Global Key Players of Integrated Precision Diagnosis and Treatment Solution Head office and Area Served

3.6 Global Key Players of Integrated Precision Diagnosis and Treatment Solution, Product and Application

3.7 Global Key Players of Integrated Precision Diagnosis and Treatment Solution, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Integrated Precision Diagnosis and Treatment Solution Breakdown Data by Type

4.1 Global Integrated Precision Diagnosis and Treatment Solution Historic Market Size by Type (2020-2025)

4.2 Global Integrated Precision Diagnosis and Treatment Solution Forecasted Market Size by Type (2026-2031)

5 Integrated Precision Diagnosis and Treatment Solution Breakdown Data by Application

5.1 Global Integrated Precision Diagnosis and Treatment Solution Historic Market Size by Application (2020-2025)

5.2 Global Integrated Precision Diagnosis and Treatment Solution Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Integrated Precision Diagnosis and Treatment Solution Market Size (2020-2031)

6.2 North America Integrated Precision Diagnosis and Treatment Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2020-2025)

6.4 North America Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Integrated Precision Diagnosis and Treatment Solution Market Size (2020-2031)

7.2 Europe Integrated Precision Diagnosis and Treatment Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2020-2025)

7.4 Europe Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size (2020-2031)

8.2 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size by Region (2020-2025)

8.4 Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Integrated Precision Diagnosis and Treatment Solution Market Size (2020-2031)

9.2 Latin America Integrated Precision Diagnosis and Treatment Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2020-2025)

9.4 Latin America Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size (2020-2031)

10.2 Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2020-2025)

10.4 Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Illumina

11.1.1 Illumina Company Details

11.1.2 Illumina Business Overview

11.1.3 Illumina Integrated Precision Diagnosis and Treatment Solution Introduction

11.1.4 Illumina Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

11.1.5 Illumina Recent Development

11.2 QIAGEN

11.2.1 QIAGEN Company Details

11.2.2 QIAGEN Business Overview

11.2.3 QIAGEN Integrated Precision Diagnosis and Treatment Solution Introduction

11.2.4 QIAGEN Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

11.2.5 QIAGEN Recent Development

11.3 Caris Life Sciences

11.3.1 Caris Life Sciences Company Details

11.3.2 Caris Life Sciences Business Overview

11.3.3 Caris Life Sciences Integrated Precision Diagnosis and Treatment Solution Introduction

11.3.4 Caris Life Sciences Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

11.3.5 Caris Life Sciences Recent Development

11.4 Foundation Medicine

11.4.1 Foundation Medicine Company Details

11.4.2 Foundation Medicine Business Overview

11.4.3 Foundation Medicine Integrated Precision Diagnosis and Treatment Solution Introduction

11.4.4 Foundation Medicine Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

11.4.5 Foundation Medicine Recent Development

11.5 Guardant Health

11.5.1 Guardant Health Company Details

11.5.2 Guardant Health Business Overview

11.5.3 Guardant Health Integrated Precision Diagnosis and Treatment Solution Introduction

11.5.4 Guardant Health Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

11.5.5 Guardant Health Recent Development

11.6 NeoGenomics

11.6.1 NeoGenomics Company Details

11.6.2 NeoGenomics Business Overview

11.6.3 NeoGenomics Integrated Precision Diagnosis and Treatment Solution Introduction

11.6.4 NeoGenomics Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

11.6.5 NeoGenomics Recent Development

11.7 Myriad Genetics

11.7.1 Myriad Genetics Company Details

11.7.2 Myriad Genetics Business Overview

11.7.3 Myriad Genetics Integrated Precision Diagnosis and Treatment Solution Introduction

11.7.4 Myriad Genetics Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

11.7.5 Myriad Genetics Recent Development

11.8 Thermo Fisher Scientific

11.8.1 Thermo Fisher Scientific Company Details

11.8.2 Thermo Fisher Scientific Business Overview

11.8.3 Thermo Fisher Scientific Integrated Precision Diagnosis and Treatment Solution Introduction

11.8.4 Thermo Fisher Scientific Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

11.8.5 Thermo Fisher Scientific Recent Development

11.9 Roche Holding AG

11.9.1 Roche Holding AG Company Details

11.9.2 Roche Holding AG Business Overview

11.9.3 Roche Holding AG Integrated Precision Diagnosis and Treatment Solution Introduction

11.9.4 Roche Holding AG Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

11.9.5 Roche Holding AG Recent Development

11.10 Abbott Laboratories

11.10.1 Abbott Laboratories Company Details

11.10.2 Abbott Laboratories Business Overview

11.10.3 Abbott Laboratories Integrated Precision Diagnosis and Treatment Solution Introduction

11.10.4 Abbott Laboratories Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

11.10.5 Abbott Laboratories Recent Development

11.11 GE HealthCare

11.11.1 GE HealthCare Company Details

11.11.2 GE HealthCare Business Overview

11.11.3 GE HealthCare Integrated Precision Diagnosis and Treatment Solution Introduction

11.11.4 GE HealthCare Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

11.11.5 GE HealthCare Recent Development

11.12 Tempus Labs

11.12.1 Tempus Labs Company Details

11.12.2 Tempus Labs Business Overview

11.12.3 Tempus Labs Integrated Precision Diagnosis and Treatment Solution Introduction

11.12.4 Tempus Labs Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

11.12.5 Tempus Labs Recent Development

11.13 Personalis

11.13.1 Personalis Company Details

11.13.2 Personalis Business Overview

11.13.3 Personalis Integrated Precision Diagnosis and Treatment Solution Introduction

11.13.4 Personalis Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

11.13.5 Personalis Recent Development

11.14 Genome Medical

11.14.1 Genome Medical Company Details

11.14.2 Genome Medical Business Overview

11.14.3 Genome Medical Integrated Precision Diagnosis and Treatment Solution Introduction

11.14.4 Genome Medical Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

11.14.5 Genome Medical Recent Development

11.15 Endeavor Biomedicines

11.15.1 Endeavor Biomedicines Company Details

11.15.2 Endeavor Biomedicines Business Overview

11.15.3 Endeavor Biomedicines Integrated Precision Diagnosis and Treatment Solution Introduction

11.15.4 Endeavor Biomedicines Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

11.15.5 Endeavor Biomedicines Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

Endeavor Biomedicines

List of Tables

Table 1. Global Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Genomics

Table 3. Key Players of Proteomics

Table 4. Key Players of Metabolomics

Table 5. Key Players of Radiomics

Table 6. Global Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate by Scenario (US$ Million): 2020 VS 2024 VS 2031

Table 7. Key Players of Clinical Diagnosis and Treatment Oriented

Table 8. Key Players of Prevention and Health Management

Table 9. Key Players of Drug Research and Development Support

Table 10. Global Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate by Delivery Format (US$ Million): 2020 VS 2024 VS 2031

Table 11. Key Players of Software Platform Type

Table 12. Key Players of Laboratory Service Type

Table 13. Global Integrated Precision Diagnosis and Treatment Solution Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 14. Global Integrated Precision Diagnosis and Treatment Solution Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 15. Global Integrated Precision Diagnosis and Treatment Solution Market Size by Region (2020-2025) & (US$ Million)

Table 16. Global Integrated Precision Diagnosis and Treatment Solution Market Share by Region (2020-2025)

Table 17. Global Integrated Precision Diagnosis and Treatment Solution Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 18. Global Integrated Precision Diagnosis and Treatment Solution Market Share by Region (2026-2031)

Table 19. Integrated Precision Diagnosis and Treatment Solution Market Trends

Table 20. Integrated Precision Diagnosis and Treatment Solution Market Drivers

Table 21. Integrated Precision Diagnosis and Treatment Solution Market Challenges

Table 22. Integrated Precision Diagnosis and Treatment Solution Market Restraints

Table 23. Global Integrated Precision Diagnosis and Treatment Solution Revenue by Players (2020-2025) & (US$ Million)

Table 24. Global Integrated Precision Diagnosis and Treatment Solution Market Share by Players (2020-2025)

Table 25. Global Top Integrated Precision Diagnosis and Treatment Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Integrated Precision Diagnosis and Treatment Solution as of 2024)

Table 26. Ranking of Global Top Integrated Precision Diagnosis and Treatment Solution Companies by Revenue (US$ Million) in 2024

Table 27. Global 5 Largest Players Market Share by Integrated Precision Diagnosis and Treatment Solution Revenue (CR5 and HHI) & (2020-2025)

Table 28. Global Key Players of Integrated Precision Diagnosis and Treatment Solution, Headquarters and Area Served

Table 29. Global Key Players of Integrated Precision Diagnosis and Treatment Solution, Product and Application

Table 30. Global Key Players of Integrated Precision Diagnosis and Treatment Solution, Date of Enter into This Industry

Table 31. Mergers & Acquisitions, Expansion Plans

Table 32. Global Integrated Precision Diagnosis and Treatment Solution Market Size by Type (2020-2025) & (US$ Million)

Table 33. Global Integrated Precision Diagnosis and Treatment Solution Revenue Market Share by Type (2020-2025)

Table 34. Global Integrated Precision Diagnosis and Treatment Solution Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 35. Global Integrated Precision Diagnosis and Treatment Solution Revenue Market Share by Type (2026-2031)

Table 36. Global Integrated Precision Diagnosis and Treatment Solution Market Size by Application (2020-2025) & (US$ Million)

Table 37. Global Integrated Precision Diagnosis and Treatment Solution Revenue Market Share by Application (2020-2025)

Table 38. Global Integrated Precision Diagnosis and Treatment Solution Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 39. Global Integrated Precision Diagnosis and Treatment Solution Revenue Market Share by Application (2026-2031)

Table 40. North America Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. North America Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2020-2025) & (US$ Million)

Table 42. North America Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2026-2031) & (US$ Million)

Table 43. Europe Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Europe Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2020-2025) & (US$ Million)

Table 45. Europe Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2026-2031) & (US$ Million)

Table 46. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 47. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size by Region (2020-2025) & (US$ Million)

Table 48. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size by Region (2026-2031) & (US$ Million)

Table 49. Latin America Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 50. Latin America Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2020-2025) & (US$ Million)

Table 51. Latin America Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2026-2031) & (US$ Million)

Table 52. Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 53. Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2020-2025) & (US$ Million)

Table 54. Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size by Country (2026-2031) & (US$ Million)

Table 55. Illumina Company Details

Table 56. Illumina Business Overview

Table 57. Illumina Integrated Precision Diagnosis and Treatment Solution Product

Table 58. Illumina Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025) & (US$ Million)

Table 59. Illumina Recent Development

Table 60. QIAGEN Company Details

Table 61. QIAGEN Business Overview

Table 62. QIAGEN Integrated Precision Diagnosis and Treatment Solution Product

Table 63. QIAGEN Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025) & (US$ Million)

Table 64. QIAGEN Recent Development

Table 65. Caris Life Sciences Company Details

Table 66. Caris Life Sciences Business Overview

Table 67. Caris Life Sciences Integrated Precision Diagnosis and Treatment Solution Product

Table 68. Caris Life Sciences Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025) & (US$ Million)

Table 69. Caris Life Sciences Recent Development

Table 70. Foundation Medicine Company Details

Table 71. Foundation Medicine Business Overview

Table 72. Foundation Medicine Integrated Precision Diagnosis and Treatment Solution Product

Table 73. Foundation Medicine Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025) & (US$ Million)

Table 74. Foundation Medicine Recent Development

Table 75. Guardant Health Company Details

Table 76. Guardant Health Business Overview

Table 77. Guardant Health Integrated Precision Diagnosis and Treatment Solution Product

Table 78. Guardant Health Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025) & (US$ Million)

Table 79. Guardant Health Recent Development

Table 80. NeoGenomics Company Details

Table 81. NeoGenomics Business Overview

Table 82. NeoGenomics Integrated Precision Diagnosis and Treatment Solution Product

Table 83. NeoGenomics Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025) & (US$ Million)

Table 84. NeoGenomics Recent Development

Table 85. Myriad Genetics Company Details

Table 86. Myriad Genetics Business Overview

Table 87. Myriad Genetics Integrated Precision Diagnosis and Treatment Solution Product

Table 88. Myriad Genetics Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025) & (US$ Million)

Table 89. Myriad Genetics Recent Development

Table 90. Thermo Fisher Scientific Company Details

Table 91. Thermo Fisher Scientific Business Overview

Table 92. Thermo Fisher Scientific Integrated Precision Diagnosis and Treatment Solution Product

Table 93. Thermo Fisher Scientific Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025) & (US$ Million)

Table 94. Thermo Fisher Scientific Recent Development

Table 95. Roche Holding AG Company Details

Table 96. Roche Holding AG Business Overview

Table 97. Roche Holding AG Integrated Precision Diagnosis and Treatment Solution Product

Table 98. Roche Holding AG Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025) & (US$ Million)

Table 99. Roche Holding AG Recent Development

Table 100. Abbott Laboratories Company Details

Table 101. Abbott Laboratories Business Overview

Table 102. Abbott Laboratories Integrated Precision Diagnosis and Treatment Solution Product

Table 103. Abbott Laboratories Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025) & (US$ Million)

Table 104. Abbott Laboratories Recent Development

Table 105. GE HealthCare Company Details

Table 106. GE HealthCare Business Overview

Table 107. GE HealthCare Integrated Precision Diagnosis and Treatment Solution Product

Table 108. GE HealthCare Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025) & (US$ Million)

Table 109. GE HealthCare Recent Development

Table 110. Tempus Labs Company Details

Table 111. Tempus Labs Business Overview

Table 112. Tempus Labs Integrated Precision Diagnosis and Treatment Solution Product

Table 113. Tempus Labs Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025) & (US$ Million)

Table 114. Tempus Labs Recent Development

Table 115. Personalis Company Details

Table 116. Personalis Business Overview

Table 117. Personalis Integrated Precision Diagnosis and Treatment Solution Product

Table 118. Personalis Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025) & (US$ Million)

Table 119. Personalis Recent Development

Table 120. Genome Medical Company Details

Table 121. Genome Medical Business Overview

Table 122. Genome Medical Integrated Precision Diagnosis and Treatment Solution Product

Table 123. Genome Medical Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025) & (US$ Million)

Table 124. Genome Medical Recent Development

Table 125. Endeavor Biomedicines Company Details

Table 126. Endeavor Biomedicines Business Overview

Table 127. Endeavor Biomedicines Integrated Precision Diagnosis and Treatment Solution Product

Table 128. Endeavor Biomedicines Revenue in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025) & (US$ Million)

Table 129. Endeavor Biomedicines Recent Development

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

Table 133. Authors List of This Report

List of Figures

Figure 1. Integrated Precision Diagnosis and Treatment Solution Picture

Figure 2. Global Integrated Precision Diagnosis and Treatment Solution Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Integrated Precision Diagnosis and Treatment Solution Market Share by Type: 2024 VS 2031

Figure 4. Genomics Features

Figure 5. Proteomics Features

Figure 6. Metabolomics Features

Figure 7. Radiomics Features

Figure 8. Global Integrated Precision Diagnosis and Treatment Solution Market Size Comparison by Scenario (2020-2031) & (US$ Million)

Figure 9. Clinical Diagnosis and Treatment Oriented Features

Figure 10. Prevention and Health Management Features

Figure 11. Drug Research and Development Support Features

Figure 12. Global Integrated Precision Diagnosis and Treatment Solution Market Size Comparison by Delivery Format (2020-2031) & (US$ Million)

Figure 13. Software Platform Type Features

Figure 14. Laboratory Service Type Features

Figure 15. Global Integrated Precision Diagnosis and Treatment Solution Market Size by Application (2020-2031) & (US$ Million)

Figure 16. Global Integrated Precision Diagnosis and Treatment Solution Market Share by Application: 2024 VS 2031

Figure 17. Medical Institutions Case Studies

Figure 18. Research and Academic Institutions Case Studies

Figure 19. Integrated Precision Diagnosis and Treatment Solution Report Years Considered

Figure 20. Global Integrated Precision Diagnosis and Treatment Solution Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 21. Global Integrated Precision Diagnosis and Treatment Solution Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 22. Global Integrated Precision Diagnosis and Treatment Solution Market Share by Region: 2024 VS 2031

Figure 23. Global Integrated Precision Diagnosis and Treatment Solution Market Share by Players in 2024

Figure 24. Global Integrated Precision Diagnosis and Treatment Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 25. The Top 10 and 5 Players Market Share by Integrated Precision Diagnosis and Treatment Solution Revenue in 2024

Figure 26. North America Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. North America Integrated Precision Diagnosis and Treatment Solution Market Share by Country (2020-2031)

Figure 28. United States Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Canada Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Europe Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Europe Integrated Precision Diagnosis and Treatment Solution Market Share by Country (2020-2031)

Figure 32. Germany Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. France Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. U.K. Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Italy Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Russia Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Ireland Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Asia-Pacific Integrated Precision Diagnosis and Treatment Solution Market Share by Region (2020-2031)

Figure 40. China Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Japan Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. South Korea Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Southeast Asia Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. India Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Australia & New Zealand Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Latin America Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Latin America Integrated Precision Diagnosis and Treatment Solution Market Share by Country (2020-2031)

Figure 48. Mexico Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Brazil Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Middle East & Africa Integrated Precision Diagnosis and Treatment Solution Market Share by Country (2020-2031)

Figure 52. Israel Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. UAE Integrated Precision Diagnosis and Treatment Solution Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Illumina Revenue Growth Rate in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

Figure 56. QIAGEN Revenue Growth Rate in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

Figure 57. Caris Life Sciences Revenue Growth Rate in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

Figure 58. Foundation Medicine Revenue Growth Rate in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

Figure 59. Guardant Health Revenue Growth Rate in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

Figure 60. NeoGenomics Revenue Growth Rate in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

Figure 61. Myriad Genetics Revenue Growth Rate in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

Figure 63. Roche Holding AG Revenue Growth Rate in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

Figure 64. Abbott Laboratories Revenue Growth Rate in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

Figure 65. GE HealthCare Revenue Growth Rate in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

Figure 66. Tempus Labs Revenue Growth Rate in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

Figure 67. Personalis Revenue Growth Rate in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

Figure 68. Genome Medical Revenue Growth Rate in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

Figure 69. Endeavor Biomedicines Revenue Growth Rate in Integrated Precision Diagnosis and Treatment Solution Business (2020-2025)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions